Funded Grants

The V Foundation’s grant making model ensures the most promising cancer research projects at state-of-the-art facilities around the country are funded. Cancer research grants are awarded to innovative researchers with the most cutting-edge ideas on how to improve cancer diagnosis methods, prevent cancer recurrences or defeat cancer. 100% of direct donations are used to fund projects we identify as the most likely to help those diagnosed with cancer.

2023
Hee Won Yang, PhD
Deciphering mechanisms of RAS inhibitor resistance in NRAS-mutant melanoma
Read More
2023
Manmeet Ahluwalia, MD, MBA, FASCO
Phase 1 Trial of Tucatinib, Trastuzumab, and Capecitabine with Stereotactic Radiosurgery (SRS)...
Read More
2023
Brian Czerniecki, MD, PhD
Targeting ER positive Breast Cancer using Immunotherapy
Read More
2023
Alejandro Gutierrez, MD
Developing Clinical GSK3a Inhibitors to Reverse Asparaginase Resistance in High-Risk Acute Leukemias...
Read More
2023
Matthew Griffin, PhD
Developing precision probiotics to overcome melanoma resistance to anti-PD-1 therapy *The research...
Read More
2023
Lindsay LaFave, PhD
Investigating chromatin-mediated mechanisms of chemo-immunotherapy resistance in lung cancer
Read More
2023
Robert Manguso, PhD
Overcoming intrinsic resistance to CAR T cell therapy in solid tumors using...
Read More
2023
Alexander Muir, PhD
Targeting nutrient microenvironment induced therapy resistance in pancreatic cancer
Read More
2023
Deepshika Ramanan, PhD
Role of the entero-mammary axis in multigenerational colorectal cancer susceptibility
Read More
2023
Peter Westcott, PhD
Modeling the evolution of immune dysfunction in cancer
Read More
2023
Jianjun Wu, PhD
Targeting cGAMP Importation into T Cells to Overcome Tumor Resistance to STING...
Read More
2023
Bingfei Yu, PhD
Targeted anti-tumor therapy by programmable viral particles
Read More
2023
Scott Armstrong, MD, PhD
Targeting Menin Inhibitor Resistance in Pediatric Leukemia
Read More
2023
Kelsey Bertrand, MSc, MD
Evaluating cellular immunotherapy as an effective treatment for high-risk pediatric brain tumors
Read More
2023
Patrick Grohar, MD, PhD
Mechanisms of Resistance for EWS-FLI1 Targeted Therapies
Read More
2023
Madeline Hayes, PhD
In vivo Characterization of Cell State Transitions Associated with DNA Damage Response...
Read More